Key Takeaways
- Emerging growth companies may submit their S-1 confidentially, allowing multiple rounds of SEC staff review to resolve disclosure and accounting issues before the registration statement becomes public and competitors can read it.
- MD&A must address known trends and uncertainties, not merely report historical results. The SEC staff scrutinizes whether management's qualitative discussion explains the drivers of financial performance rather than restating numbers from the financial statements.
- Executive compensation disclosure requirements differ materially between emerging growth companies, smaller reporting companies, and accelerated filers. Pay-versus-performance tables are required for accelerated filers but EGCs are exempt, making EGC status a meaningful administrative benefit.
- The SEC comment letter process is iterative and often produces two or more rounds of comments before the staff issues a no-further-comment letter. Issuers who build adequate time into their IPO timeline for multiple comment rounds avoid the compressing pressure of a market window that closes before the review is complete.
The Form S-1 registration statement is the legal foundation of a domestic initial public offering. Filed with the Securities and Exchange Commission under Section 5 of the Securities Act of 1933, it registers the securities to be offered and sold in the IPO and contains the prospectus that must be delivered to investors before or at the time of sale. The S-1 is not merely a disclosure document: it is the product of a legal drafting process that engages company counsel, underwriter counsel, auditors, and senior management over a period of months, and it is reviewed by the SEC staff in a comment letter process that tests the completeness and accuracy of every material disclosure the issuer makes.
This sub-article is part of the IPO Readiness: Legal Guide. It covers the full structure of the Form S-1 in detail: the confidential submission process available to emerging growth companies; the content requirements for each major section of the prospectus; the financial statement requirements, including audit standards and the period of financial statements required at filing; executive compensation disclosure obligations, including the application of pay-versus-performance rules; the SEC staff review process and how to manage comment letters; the amendment process; and the mechanics of pricing and effectiveness.
Acquisition Stars advises issuers, underwriters, and selling stockholders on IPO registration statement preparation, SEC comment letter responses, and the full range of securities law compliance obligations in a public offering. Nothing in this article constitutes legal advice for any specific transaction.
The Legal Framework: Securities Act Section 5 and the Registration Requirement
Section 5 of the Securities Act of 1933 prohibits the offer or sale of any security unless a registration statement covering that security is in effect, unless an exemption from registration applies. For a domestic company conducting an IPO on a U.S. stock exchange or Nasdaq, no exemption is available: the offering must be registered, and the registration statement must contain a prospectus meeting the disclosure requirements specified in the SEC's rules under the Securities Act.
The registration statement has two parts: Part I, which is the prospectus delivered to investors, and Part II, which contains supplemental information including a list of exhibits, the undertakings required by SEC rules, and the signatures of the registrant and its principal officers and directors. Part I is the public-facing disclosure document. Part II is filed with the SEC but is not required to be delivered to investors as part of the prospectus, though it is available on EDGAR.
The prospectus delivery requirement applies from the date the registration statement is filed (the pre-effective period), during which only certain limited communications are permitted, through the post-effective period following closing of the offering. During the pre-effective period, the issuer may distribute a preliminary prospectus (commonly called a "red herring" because of the mandatory legend printed in red on its cover) to solicit indications of interest from investors, but may not accept binding orders until the registration statement is effective. The final prospectus, reflecting the offering price and number of shares, is filed with the SEC under Rule 424(b) and constitutes the document on which investors may rely for their Securities Act Section 11 claims.
Confidential Submission for Emerging Growth Companies
The JOBS Act of 2012 created the category of "emerging growth company" (EGC) and, among other accommodations, permitted EGCs to submit their initial registration statement to the SEC on a confidential basis before filing publicly. The confidential draft registration statement (CDRS) process allows the issuer to receive and respond to SEC staff comments without making the registration statement, or the comments themselves, publicly available during that period. The issuer must file the registration statement publicly at least 15 days before the commencement of the roadshow, at which point all prior confidential submissions and the SEC's comment letters and the issuer's responses become publicly available on EDGAR.
The practical benefit of the confidential submission process is substantial. An IPO issuer typically has significant unresolved accounting, disclosure, and legal issues at the time it first submits the registration statement to the SEC. The comment letter process surfaces those issues in written form and requires the issuer to address them in the registration statement. Working through those issues confidentially means that the public version of the registration statement is a materially more refined document than the initial submission, and that the company's first public disclosure of sensitive business information is presented in a form that has already been reviewed by the SEC staff. This is particularly valuable for companies with complex revenue recognition issues, unusual business models, or pending litigation that must be disclosed.
EGC status is available to companies with total annual gross revenues below $1.235 billion (as adjusted for inflation) in their most recently completed fiscal year. A company retains EGC status until the earliest of: the last day of its fiscal year in which it had total annual gross revenues of $1.235 billion or more; the last day of its fiscal year following the fifth anniversary of the IPO; the date on which the company has issued more than $1 billion in non-convertible debt in the previous three years; or the date on which the company becomes a large accelerated filer. EGC status carries several additional accommodations beyond confidential submission, including the ability to provide only two years of audited financial statements (rather than three) and exemption from the pay-versus-performance disclosure requirement.
Prospectus Structure: Cover Page, Summary, and Use of Proceeds
The prospectus begins with a cover page that identifies the issuer, describes the securities being offered, states the offering price or the price range if pricing has not yet been determined, and includes the names of the underwriters. The cover page also includes mandatory legends required by SEC rules, including the statement that the SEC has neither approved nor disapproved the securities and the statement that the prospectus is a preliminary document if the price range has not been set. The format and content of the cover page is dictated by Item 501 of Regulation S-K and must be followed precisely.
Immediately following the cover page, most prospectuses include a summary section that provides a condensed overview of the company's business, the offering, and the key risk factors. The summary is not required by SEC rules but is standard practice because it provides investors with a quick orientation before they reach the more detailed disclosures that follow. The SEC staff reviews the summary for consistency with the more detailed disclosures elsewhere in the prospectus, and inconsistencies between the summary and the body of the prospectus are a common source of comments.
The use of proceeds section, required by Item 504 of Regulation S-K, discloses the principal purposes for which the net proceeds of the offering will be used and, to the extent determinable, the approximate amount intended to be used for each purpose. The SEC staff expects the use of proceeds disclosure to be specific rather than generic. Statements that proceeds will be used for "general corporate purposes" or "working capital" without further elaboration draw comments requiring more specificity about how the company intends to use the proceeds. If a portion of the proceeds will be used to repay existing indebtedness, the terms of that indebtedness and the identity of the lenders must be disclosed.
Business Section Requirements
The business section of an S-1, governed by Item 101 of Regulation S-K, must provide a description of the company's business that is sufficient for investors to understand the nature of the company's operations, its competitive position, its key products or services, the markets it serves, and the material regulatory framework applicable to its industry. The business section is typically the longest narrative section of the prospectus and the one that receives the most substantive SEC staff comments, because the quality of the business description directly determines whether investors can make an informed assessment of the company's prospects.
The business section must identify the company's principal products or services and describe their development status, revenue contribution, and the competitive advantages the company believes they provide. It must describe the company's distribution and marketing methods, the sources of its raw materials or key inputs, the importance of any patents, trademarks, or other intellectual property, the seasonality of the business, the extent of any concentration in customer relationships, and any material regulatory requirements applicable to the company's products or operations. For technology companies, the SEC staff frequently comments on whether the business section adequately describes the company's technology in terms that a non-technical investor can understand.
The competitive landscape disclosure within the business section requires identification of the company's principal competitors and a description of the basis on which the company competes with them. The SEC staff does not require the issuer to make predictions about competitive outcomes but does require that the description be accurate and not misleading. Companies that describe their competitive position using broad market share claims or unsourced data comparing their performance favorably to unnamed competitors frequently receive comments requiring either specific sourcing for the claims or deletion of the unsupported comparison.
Risk Factor Drafting Standards
The risk factor section, governed by Item 105 of Regulation S-K (revised in 2020), requires disclosure of material factors that make the offering speculative or risky. The 2020 amendments added a requirement that issuers include a summary of the risk factors if the risk factor section exceeds 15 pages, and they expressly require that risk factors be organized under relevant headings to facilitate investor navigation. The amendments also require risk factors to be specific and not generic, and they authorize the SEC staff to comment on risk factors that lack specificity or that duplicate disclosures appearing elsewhere without adding informational value.
The drafting standard for risk factors is materiality combined with specificity. A risk is material if a reasonable investor would consider it important in deciding whether to invest. Specificity means that the risk factor must describe the particular risk the issuer faces, not a general industry condition that applies equally to all participants. A risk factor that states "we operate in a competitive market" without explaining the specific competitive dynamics that threaten the issuer's business is generic boilerplate that adds no informational value and draws SEC comment. A risk factor that identifies a specific competitor, describes the basis on which that competitor is gaining market share, and explains the mechanism by which the competition could adversely affect the issuer's revenue meets the specificity standard.
Risk factors must be consistent with the rest of the prospectus. If the business section describes the company's technology as differentiated and difficult for competitors to replicate, the risk factor section cannot simultaneously include a risk factor stating that the company's technology has no meaningful competitive advantage without explaining the apparent inconsistency. The SEC staff reviews risk factors for internal consistency with the business section, MD&A, and financial statements, and inconsistencies between sections are a persistent source of multiple-comment-round disputes in S-1 reviews.
MD&A Structure: Results, Liquidity, Trends, and Critical Accounting
Management's Discussion and Analysis (MD&A), governed by Item 303 of Regulation S-K, is the section of the prospectus where management provides its own analysis of the company's financial condition and results of operations, as opposed to the financial statements, which present the numbers without management commentary. The SEC's 2020 amendments to Item 303 reorganized the MD&A requirements and emphasized that the objective is to provide investors with a view of the company through the eyes of management, meaning that the MD&A must contain qualitative explanation of why financial results changed, not merely a recitation of the numbers with the observation that they increased or decreased.
The results of operations discussion must cover each component of revenue and each material line item of expense for each fiscal year presented in the financial statements, explaining the factors that drove changes from year to year. For a company with multiple revenue streams, the SEC staff expects a disaggregated discussion of each stream rather than a blended discussion that obscures the drivers of performance in individual categories. Operating expenses must be discussed at a level of detail sufficient to identify whether cost increases reflect investment in growth, inflation in input costs, or operational inefficiencies, and the MD&A must be consistent with the notes to the financial statements that address the same costs.
The liquidity and capital resources section must address the company's ability to fund its operations, capital expenditures, and debt obligations for the next twelve months, and must identify any known sources of liquidity risk. Companies that are not cash-flow positive must disclose that fact and explain how they intend to fund operations through the next twelve months, including the extent to which they plan to rely on the IPO proceeds, future equity or debt issuances, or other external sources. The SEC staff frequently comments on liquidity disclosures that are conclusory or that fail to address specific near-term obligations the company faces, such as lease commitments, debt maturities, or contractual purchase obligations.
The known trends and uncertainties section of the MD&A requires management to disclose any known trend, demand, commitment, event, or uncertainty that is reasonably likely to have a material effect on the company's financial condition or results of operations. This requirement is often the most litigated aspect of MD&A, because it asks management to make forward-looking disclosures about conditions they may prefer to characterize as uncertain rather than known. The SEC staff applies an objective standard: if management is actually aware of a trend or uncertainty, it must disclose it, even if management does not know its ultimate impact. The failure to disclose a known adverse trend is a basis for SEC enforcement and private securities litigation.
Critical accounting estimates are those that require management to make judgments about matters that are inherently uncertain and where the reasonably possible changes in those judgments could have a material impact on the financial statements. Revenue recognition, goodwill impairment, stock-based compensation fair value, and contingent liability accruals are the most common subjects of critical accounting estimate disclosure in S-1 filings. The SEC staff expects the critical accounting estimate discussion to go beyond a description of the accounting policy and to explain the specific assumptions management makes, the sensitivity of the financial results to those assumptions, and the basis on which management formed its judgments.
Executive Compensation Disclosure: CD&A, Summary Table, and Pay-Versus-Performance
Executive compensation disclosure in an S-1 is governed by Item 402 of Regulation S-K, which establishes different disclosure requirements based on the issuer's reporting status. Non-smaller reporting companies that are not EGCs must provide the most extensive disclosure, including a Compensation Discussion and Analysis (CD&A) that explains the compensation program's objectives, the decisions made by the compensation committee, and the relationship between compensation and company performance. Smaller reporting companies may use a simplified disclosure format that omits the CD&A and several supplemental tables but still requires a Summary Compensation Table and a description of outstanding equity awards. EGCs may use the scaled disclosure applicable to smaller reporting companies regardless of their size during the EGC period.
The CD&A must be written in plain English and must address, at a minimum: the objectives of the compensation program; what the program is designed to reward; each element of compensation; why the company pays each element; how the company determines the amounts of each element; and how each element relates to the company's objectives and to compensation decisions for other elements. The CD&A is the narrative complement to the tabular disclosures that follow it, and the SEC staff requires that the CD&A provide genuine insight into the compensation committee's decision-making process rather than generic statements about pay-for-performance philosophy without reference to actual decisions made in the reported year.
The Summary Compensation Table is the central tabular disclosure, providing total compensation for each named executive officer (NEO) for the three most recent fiscal years. NEOs are identified as the principal executive officer, the principal financial officer, and the three most highly compensated other executive officers serving at the end of the fiscal year (plus up to two additional individuals who would have qualified based on compensation if they had been serving at year-end). The table includes columns for salary, bonus, stock awards (at grant date fair value), option awards (at grant date fair value), non-equity incentive plan compensation, changes in pension value, all other compensation, and total.
The pay-versus-performance (PvP) disclosure, required since 2023 for accelerated filers under the 2022 SEC amendments, requires issuers to present a table showing "compensation actually paid" (CAP) to the principal executive officer and the average CAP to all other NEOs, alongside specified financial performance measures, for each of the three to five most recent fiscal years (five years after full phase-in). CAP differs from the total compensation shown in the Summary Compensation Table primarily because equity awards are reflected at their fair value on vesting date (or year-end if unvested) rather than at grant date fair value. For most pre-IPO companies that were granting equity heavily at low valuations, the PvP calculation can produce significantly higher CAP numbers than the Summary Compensation Table reflects, particularly if the IPO price represents a substantial step-up from prior grant prices.
Beneficial Ownership and Related Party Transactions
The beneficial ownership table, required by Item 403 of Regulation S-K, discloses the number and percentage of shares owned by each director, each NEO, all directors and executive officers as a group, and each person or entity that owns more than five percent of any class of the registrant's securities. Beneficial ownership includes shares owned directly and shares that can be acquired within 60 days through the exercise of options, warrants, or conversion rights. The table must be presented both before and after the offering to show the dilutive effect of the IPO.
For pre-IPO companies that have issued multiple series of preferred stock, the beneficial ownership calculation requires careful attention to the treatment of as-converted shares. Each series of preferred stock converts to common stock at a defined ratio, and the beneficial ownership table must reflect the as-converted common stock equivalents for all preferred holders who meet the five percent threshold, not merely the number of preferred shares held. Companies with complex capitalization structures that include multiple preferred series, warrants, and convertible notes must prepare a fully diluted beneficial ownership analysis before drafting the table to ensure that all reportable holders and their ownership percentages are correctly identified.
Related party transaction disclosure under Item 404 of Regulation S-K requires a description of any transaction since the beginning of the company's last fiscal year in which the company was a party, the amount exceeded $120,000, and a related person had a material interest. For most IPO issuers, the most significant related party transactions include founder loans that must be repaid before or at IPO closing, compensation arrangements with entities controlled by founders or directors, subleases or property licenses involving founder-affiliated landlords, and supply agreements with companies in which directors or major stockholders hold interests. The SEC staff expects the related party disclosure to include the business purpose of each transaction, the terms on which it was entered into, whether those terms were arm's length, and whether any conflict of interest existed in the decision-making process.
Financial Statements: Audit Requirements and Periods
The financial statements required in an S-1 are audited balance sheets, statements of operations, statements of cash flows, and statements of stockholders' equity for the periods specified by Rule 3-02 of Regulation S-X. Non-EGC issuers must provide three years of audited financial statements. EGCs may provide two years of audited financial statements. In both cases, the audit must be conducted under Public Company Accounting Oversight Board (PCAOB) standards, and the auditor must be registered with the PCAOB, which is a significant requirement for companies that have previously used non-PCAOB-registered auditors during their private company period.
The financial statements in an S-1 must be as of a date no more than 135 days before the effective date for large accelerated filers, and no more than 135 days for other issuers in most circumstances. As a practical matter, this means that a company filing in the spring must have audited financial statements for the preceding fiscal year, and if the IPO process extends past a certain date (typically late summer for a December 31 fiscal year end company), interim unaudited financial statements for the most recently completed quarter must be included and reviewed (but not audited) by the company's auditors.
Companies that have completed acquisitions during the periods presented in the financial statements may be required to include financial statements for the acquired entity under Rule 3-05 of Regulation S-X, depending on the size of the acquisition relative to the registrant. Rule 3-05 financial statements must also be audited under PCAOB standards. Companies that were private at the time of an acquisition and used a non-PCAOB-registered auditor for the target's historical financial statements must retroactively re-audit those statements with a PCAOB-registered firm if the acquisition requires Rule 3-05 disclosure, a process that can add months to the IPO preparation timeline.
Underwriting Section and Exhibits
The underwriting section of the prospectus describes the terms and conditions of the underwriting arrangement between the issuer and the underwriters. For a firm commitment offering, the underwriting agreement obligates the underwriters to purchase all shares offered at the offering price less the underwriting discount, and to reoffer those shares to the public at the offering price. The underwriting section discloses the underwriting discount (expressed as a percentage of the gross offering proceeds), any selling concessions or discounts available to certain dealers, and the over-allotment option (commonly called the "greenshoe") that allows the underwriters to purchase additional shares at the offering price to cover short positions created in connection with the offering.
The underwriting section must also disclose any stabilizing bids or transactions that the underwriters may effect to maintain the market price of the shares during the offering period. Stabilization is a permitted form of market activity that allows underwriters to bid for shares at or below the offering price to prevent the market price from falling below the offering price during the distribution period. The prospectus must describe the nature, purpose, and potential effect of stabilization in terms that are sufficiently clear that investors understand the underwriters may be supporting the market price.
The exhibits to Part II of the registration statement include all material contracts, the company's charter and bylaws, legal opinions, auditor consents, and any other documents required by Item 601 of Regulation S-K. The legal opinion from company counsel must address whether the shares offered are validly issued, fully paid, and non-assessable. The auditor consent authorizes the inclusion of the audit report in the registration statement and must be updated (re-filed) each time the registration statement is amended. Material contracts for purposes of Item 601 include contracts not made in the ordinary course of business that are material to the company, and all compensation plans, contracts, and arrangements in which directors or NEOs participate.
The SEC Comment Letter Process
After a registration statement is filed, it is assigned to a reviewing team within the SEC's Division of Corporation Finance. The staff reviews the document for completeness and compliance with the applicable disclosure rules, and then issues a comment letter identifying specific deficiencies or requesting additional information. The SEC's internal goal is to issue the initial comment letter within 30 days of the filing date for IPO registration statements. Comment letters are publicly available on EDGAR after the issuer receives them and after the staff confirms that confidential treatment is not required for any portion.
The issuer must respond to each comment in the comment letter, either by revising the registration statement to address the comment or by explaining in the response letter why the current disclosure is adequate and no revision is required. SEC comment letter responses are formal legal documents that are filed with the SEC and become part of the public record. The response letter must address each comment individually, with specific references to the pages and line numbers in the revised registration statement where responsive changes have been made. Responses that are vague or that do not address the specific concern the staff raised typically generate a follow-up comment in the next comment letter, extending the review timeline.
The most common subjects of SEC comments in IPO registration statements are revenue recognition under ASC 606, segment reporting and whether the company has appropriately identified its reportable segments, non-GAAP financial measures and whether they comply with Regulation G and Item 10(e) of Regulation S-K, MD&A trends and uncertainties, risk factor specificity, and related party transaction disclosure completeness. Companies that anticipate significant comment activity in any of these areas should prepare responsive disclosure in the initial draft rather than waiting for the comment letter to surface the issue.
When the staff is satisfied with the issuer's responses and the revised registration statement, it issues a no-further-comment letter (also called a "clear" or "no objection" letter). The no-further-comment letter does not mean the SEC has approved the registration statement or the offering: it means only that the staff has no further questions about the disclosure as presented. The registration statement may then be declared effective upon the issuer's request, typically on the morning of pricing following the roadshow.
Amendments, Pricing, and the Effective Date
Registration statement amendments are filed as Amendment No. 1, Amendment No. 2, and so on, and each amendment updates the registration statement to reflect changes to the disclosure, revised financial statements, or responses to SEC comments. Amendments filed in response to SEC comments are typically filed as complete restated documents (rather than marked-up versions) with a separate comment response letter. Amendments that are filed solely to update the financial statements for a new period (for example, to add a quarterly period that has become stale) are filed as separate amendments and do not require re-review of sections that have not changed.
The pricing amendment, filed shortly before the registration statement is declared effective, updates the preliminary prospectus to include the final offering price, the number of shares to be sold in the offering, the underwriting discount, and the net proceeds to the issuer. This amendment is filed after the pricing meeting at which the underwriters and the issuer agree on the final terms. For large offerings that use the Rule 430A procedure, the pricing information may be omitted from the registration statement at the time it is declared effective and then included in the final prospectus filed under Rule 424(b) within two business days of effectiveness. The Rule 430A procedure allows the offering to proceed without a final amendment if the only open item is the price.
The registration statement is declared effective by the SEC pursuant to the issuer's request under Section 8(a) of the Securities Act, typically by order issued on the morning of pricing before the markets open. Once effective, the issuer and the underwriters may accept binding orders from investors, and the offering closes (typically one business day after pricing under T+1 settlement). The final prospectus is filed under Rule 424(b)(4) and constitutes the document that investors may rely on for their Section 11 claims. The issuer's and underwriters' due diligence obligations under Section 11 require that the prospectus be accurate and complete as of the effective date.
Frequently Asked Questions
What is a confidential submission and who is eligible to use it?
Emerging growth companies (EGCs) under the JOBS Act may submit their initial Form S-1 registration statement to the SEC on a confidential basis before filing publicly. The confidential draft registration statement (CDRS) is reviewed by the SEC staff, which issues comments, and the issuer responds through one or more confidential rounds before filing the registration statement publicly at least 15 days before the roadshow. The practical effect is that EGCs can work through significant disclosure and accounting issues with the SEC without those discussions being visible to competitors, customers, or the market during the sensitive pre-IPO preparation period. Non-EGC issuers cannot use the confidential submission process unless the SEC extends the accommodation through no-action guidance.
What is the standard for drafting risk factors in an S-1?
SEC rules require that risk factors be specific to the issuer and the offering and not generic boilerplate applicable to any company in the industry. Each risk factor must describe both the risk and its potential consequences for the company, and risk factors must be organized under subcaptions if they are lengthy. The SEC staff frequently comments on risk factors that are vague, that bury the actual risk under general industry language, or that duplicate disclosure appearing elsewhere in the prospectus without adding substance. The legal standard for materiality in risk factor disclosure is whether a reasonable investor would consider the information important in deciding whether to invest, and issuers should apply that standard rather than attempting to hedge against every conceivable adverse outcome with generic cautionary language.
What must Management's Discussion and Analysis cover in an IPO registration statement?
MD&A must cover results of operations for each reported fiscal year, including a discussion of revenues, operating expenses, and net income or loss with a qualitative explanation of the factors driving changes from period to period rather than merely restating the numbers. It must also cover liquidity and capital resources, including the company's sources of cash, its uses of cash, and its assessment of whether existing cash resources are sufficient to fund operations for the next twelve months. Known trends, demands, commitments, and uncertainties that are reasonably likely to have a material effect on the company's financial condition or results of operations must be disclosed. Critical accounting estimates, which are those that involve significant management judgment and whose reasonably possible changes would have a material impact on the financial statements, must be identified and explained.
What executive compensation information must be disclosed in an S-1?
An S-1 for a non-smaller reporting company must include a Compensation Discussion and Analysis (CD&A) describing the objectives and outcomes of the executive compensation program for named executive officers (NEOs), a Summary Compensation Table showing total compensation for the three most recent fiscal years for each NEO, a Grants of Plan-Based Awards Table for the most recent fiscal year, an Outstanding Equity Awards at Fiscal Year-End Table, and an Option Exercises and Stock Vested Table. Smaller reporting companies may omit the CD&A and several tables but must still provide a simplified Summary Compensation Table and outstanding award disclosure. Pay-versus-performance disclosure, which became required for accelerated filers under the 2022 SEC amendments to Item 402, must also be included for covered companies.
What is the pay-versus-performance disclosure requirement and who must comply?
The SEC's pay-versus-performance rules, adopted in August 2022 as amendments to Item 402 of Regulation S-K, require covered issuers to provide a table showing the relationship between compensation actually paid (CAP) to named executive officers and the company's financial performance over the most recent three to five fiscal years. CAP differs from total compensation as reported in the Summary Compensation Table because it adjusts for the fair value of equity awards as vested rather than as granted, among other adjustments specified in the rule. Smaller reporting companies must provide a simplified version of the table covering two rather than five years. Emerging growth companies are exempt from the pay-versus-performance requirement, which is a meaningful administrative benefit for EGCs preparing their initial S-1.
How must related party transactions be disclosed in an S-1?
Regulation S-K Item 404 requires disclosure of any transaction or series of similar transactions since the beginning of the company's last fiscal year in which the company was or is to be a party, the amount involved exceeded $120,000, and any related person had or will have a direct or indirect material interest. Related persons include directors, director nominees, executive officers, holders of more than five percent of any class of voting securities, and immediate family members of those persons. IPO issuers frequently have significant related party transactions accumulated during the private company period, including loans to founders, compensation arrangements with founder-controlled entities, intellectual property licenses, and leases of property owned by founders or their affiliates. Each such transaction must be described with sufficient specificity that investors can assess whether the terms were arm's length and whether any conflicts of interest exist.
What is the SEC comment letter process and how long does it take?
After a registration statement is filed, the SEC staff reviews the document and issues a comment letter identifying areas where additional disclosure or clarification is required. The issuer responds to each comment in writing, either by revising the registration statement to incorporate the requested disclosure or by explaining why the existing disclosure is adequate. The SEC staff then issues a second comment letter if any responses are insufficient, and the process continues until the staff issues a no-further-comment letter. The initial SEC comment letter is typically issued within 30 days of the initial filing for IPOs (or within 30 days of the public filing for EGC confidential submissions). Total review time from initial filing to a no-further-comment letter varies widely based on the complexity of the filing and the nature of the comments, ranging from six to twelve weeks for straightforward filings and longer for complex accounting or disclosure issues.
How does the registration statement become effective and when can shares be sold?
A registration statement becomes effective either through an automatic effectiveness order under Rule 462(b) for an additional amount of securities or through an order of effectiveness from the SEC. For most IPOs, the issuer requests that the SEC declare the registration statement effective on the morning of pricing, which occurs after the roadshow has concluded and the underwriters have gathered indications of interest sufficient to set the final offering price. The final prospectus, reflecting the offering price and the number of shares to be sold, is filed with the SEC under Rule 424(b) within two business days of the effectiveness date. Shares may be sold and the IPO may close upon effectiveness, subject to the standard T+1 settlement cycle for equity offerings.
Related Reading
Counsel for IPO Registration Statement Preparation
Acquisition Stars advises issuers, underwriters, and selling stockholders on Form S-1 preparation, SEC comment letter strategy, prospectus disclosure, and the full legal process from confidential submission through effective registration. Submit your transaction details for an initial assessment.